Cite
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.
MLA
Rocha, C. R. R., et al. “Glutathione Depletion Sensitizes Cisplatin- and Temozolomide-Resistant Glioma Cells in Vitro and in Vivo.” Cell Death & Disease, vol. 6, Apr. 2015, p. e1727. EBSCOhost, https://doi.org/10.1038/cddis.2015.101.
APA
Rocha, C. R. R., Garcia, C. C. M., Vieira, D. B., Quinet, A., de Andrade-Lima, L. C., Munford, V., Belizário, J. E., & Menck, C. F. M. (2015). Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death & Disease, 6, e1727. https://doi.org/10.1038/cddis.2015.101
Chicago
Rocha, C R R, C C M Garcia, D B Vieira, A Quinet, L C de Andrade-Lima, V Munford, J E Belizário, and C F M Menck. 2015. “Glutathione Depletion Sensitizes Cisplatin- and Temozolomide-Resistant Glioma Cells in Vitro and in Vivo.” Cell Death & Disease 6 (April): e1727. doi:10.1038/cddis.2015.101.